MedTrace Logo

Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis

NCT04551781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2020-09-16

No results posted yet for this study

Summary

A randomized controlled trial to study the efficacy of low dose steroid for 14 days in the treatment of post-covid-19 lung infiltrates

Conditions

  • Covid19

Interventions

DRUG

20 Mg Prednisone for 14 days

20 Mg Prednisone for 14 days

DRUG

control

symptomatic ttt

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • alaa DR Rashad, MD · south-Vally Universty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-07-30
Completion
2020-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04551781 on ClinicalTrials.gov